InvestorsHub Logo
Followers 38
Posts 5145
Boards Moderated 2
Alias Born 08/05/2002

Re: weazelboy post# 3674

Wednesday, 10/15/2014 10:46:47 PM

Wednesday, October 15, 2014 10:46:47 PM

Post# of 9349
Well,

I see we have the usual "high quality" analysis of the information provided at the shareholder meeting today. ROFLMAO !!!! Watch out ... the sky is falling.

As has been mentioned before, there has been a large 6 digit offer sitting just above the market for some time. My assumption is that offer is from a prior financing that was converted to stock several months ago. Reality is 340,000 shares is not much more than $37k or so ..... not alot of money really but a challenge to the stock price given the lack of buyers.

Again the positive advances towards licensing and positive bioactive results for both canine and bovine applications are overwhelmed by the constant message "we need money" and the new assertion .... "we're considering the possibility of a reverse split". Strategic communication absolutely sucks.

How about that canine slide on comparison results between the bioactive, prescription drug diclofenac and glucosamine eh ??? Looks like the "vehicle", glucosamine and HEP2 didn't do much .... but HEP3 and HEP4 moving towards the results achieved by a 3mg dose of diclofenac. Once these results are locked down and confirmed .... HEPI should be touting those results at every possible chance and should not have an issue finding a partner to license the application.


Or maybe the bovine preliminary test data slide. Ya know those tests being done by Zoetis' hand picked CRO. Lotta green in the intramammary section.

Amigo Mike
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZIVO News